US Stock MarketDetailed Quotes

GDRX GoodRx

Watchlist
  • 8.230
  • +0.670+8.86%
Close Aug 23 16:00 ET
  • 8.280
  • +0.050+0.61%
Post 20:02 ET
3.12BMarket Cap-58785P/E (TTM)

GoodRx Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

GoodRx Q2 2024 Earnings Date

Currency：USDAug 8, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
200.43M
200.61M
+181.84K
Beat Est.
+5.67%
+5.76%
+0.09%
EPS
0.03
0.02
-0.01
Miss Est.
-76.86%
-85.71%
-38.27%
Analyst Rating
Buy

Aug 24, 2024

GoodRx Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 14 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 206.373M--
--2024/Q3-- / 195.648M--
Aug 8, 20242024/Q2200.610M / 200.428M--
May 9, 20242024/Q1197.880M / 196.098M--
Feb 29, 20242023/Q4196.644M / 195.873M--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 206.373M--
--2024/Q3-- / 195.648M--
Aug 8, 20242024/Q2200.610M / 200.428M--
May 9, 20242024/Q1197.880M / 196.098M--
Feb 29, 20242023/Q4196.644M / 195.873M--

Unlock Free Earnings Estimates

GoodRx Earnings Reports

  • GoodRx | 10-Q: Q2 2024 Earnings Report

    Aug 8 13:19 ET

  • GoodRx | 10-Q: Q1 2024 Earnings Report

    May 9 15:58 ET

  • GoodRx | 10-K: FY2023 Annual Report

    Feb 29 14:09 ET

  • GoodRx | 10-Q: Q3 2023 Earnings Report

    Nov 9, 2023 14:21 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Aug 24, 2024

    Buy

    • Buy

      50.00%

    • Hold

      41.67%

    • Sell

      8.33%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg